Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Moriarty

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Clinical Pharmacology and Therapeutics|June 6, 2026
Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support DeprescribingZakir Khan, Frank Moriarty
Basic & Clinical Pharmacology & Toxicology|May 14, 2023
Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional studiesFrank Moriarty, Carmel M Hughes
Family Practice|November 22, 2019
A comparison of contemporary versus older studies of aspirin for primary preventionFrank Moriarty, Mark H Ebell
American Family Physician|June 15, 2021
Predicting True Penicillin Allergy in AdultsSeán O Whelan, Frank Moriarty
BJGP Open|November 26, 2024
Potentially inappropriate prescribing in middle-aged adults: a significant problem with a lack of action and evidence to address itMichael Naughton, Frank Moriarty, Patrick Redmond
Heart (British Cardiac Society)|August 4, 2018
Fixed-dose combination antihypertensives and risk of medication errorsFrank Moriarty, Kathleen Bennett, Tom Fahey
Health Policy (Amsterdam, Netherlands)|August 25, 2021
Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational studyFrank Moriarty, James Larkin, Tom Fahey
Research in Social & Administrative Pharmacy : RSAP|July 10, 2021
'More of an art than a science'? The development, design and mechanics of the Delphi TechniqueSarah Drumm, Catriona Bradley, Frank Moriarty
HRB Open Research|April 15, 2021
Efficacy and safety of sacubitril/valsartan in the treatment of heart failure: protocol for a systematic review incorporating unpublished clinical study reportsDavid Byrne, Tom Fahey, Frank Moriarty
Research in Social & Administrative Pharmacy : RSAP|May 26, 2021
Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected dataFrank Moriarty, Wade Thompson, Fiona Boland
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Clinical Pharmacology and Therapeutics|June 6, 2026
Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support DeprescribingZakir Khan, Frank Moriarty
Basic & Clinical Pharmacology & Toxicology|May 14, 2023
Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional studiesFrank Moriarty, Carmel M Hughes
Family Practice|November 22, 2019
A comparison of contemporary versus older studies of aspirin for primary preventionFrank Moriarty, Mark H Ebell
American Family Physician|June 15, 2021
Predicting True Penicillin Allergy in AdultsSeán O Whelan, Frank Moriarty
BJGP Open|November 26, 2024
Potentially inappropriate prescribing in middle-aged adults: a significant problem with a lack of action and evidence to address itMichael Naughton, Frank Moriarty, Patrick Redmond
Heart (British Cardiac Society)|August 4, 2018
Fixed-dose combination antihypertensives and risk of medication errorsFrank Moriarty, Kathleen Bennett, Tom Fahey
Health Policy (Amsterdam, Netherlands)|August 25, 2021
Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational studyFrank Moriarty, James Larkin, Tom Fahey
Research in Social & Administrative Pharmacy : RSAP|July 10, 2021
'More of an art than a science'? The development, design and mechanics of the Delphi TechniqueSarah Drumm, Catriona Bradley, Frank Moriarty
HRB Open Research|April 15, 2021
Efficacy and safety of sacubitril/valsartan in the treatment of heart failure: protocol for a systematic review incorporating unpublished clinical study reportsDavid Byrne, Tom Fahey, Frank Moriarty
Research in Social & Administrative Pharmacy : RSAP|May 26, 2021
Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected dataFrank Moriarty, Wade Thompson, Fiona Boland
Pageof 17